- Home
- PBYI vs RMNI Comparison
PBYI vs RMNI Comparison
Compare PBYI & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- RMNI
- Stock Information
- Founded
- PBYI 2010
- RMNI 2005
- Country
- PBYI United States
- RMNI United States
- Employees
- PBYI N/A
- RMNI N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- RMNI Business Services
- Sector
- PBYI Health Care
- RMNI Consumer Discretionary
- Exchange
- PBYI Nasdaq
- RMNI Nasdaq
- Market Cap
- PBYI 176.1M
- RMNI 164.6M
- IPO Year
- PBYI N/A
- RMNI N/A
- Fundamental
- Price
- PBYI $2.58
- RMNI $1.83
- Analyst Decision
- PBYI Strong Buy
- RMNI Hold
- Analyst Count
- PBYI 1
- RMNI 1
- Target Price
- PBYI $7.00
- RMNI N/A
- AVG Volume (30 Days)
- PBYI 338.9K
- RMNI 174.7K
- Earning Date
- PBYI 10-31-2024
- RMNI 10-30-2024
- Dividend Yield
- PBYI N/A
- RMNI N/A
- EPS Growth
- PBYI N/A
- RMNI 340.37
- EPS
- PBYI 0.18
- RMNI 0.18
- Revenue
- PBYI $219,143,000.00
- RMNI $429,431,000.00
- Revenue This Year
- PBYI N/A
- RMNI N/A
- Revenue Next Year
- PBYI N/A
- RMNI N/A
- P/E Ratio
- PBYI $14.09
- RMNI $9.96
- Revenue Growth
- PBYI N/A
- RMNI 1.64
- 52 Week Low
- PBYI $2.13
- RMNI $1.55
- 52 Week High
- PBYI $7.73
- RMNI $3.44
- Technical
- Relative Strength Index (RSI)
- PBYI 44.27
- RMNI 45.49
- Support Level
- PBYI $2.48
- RMNI $1.77
- Resistance Level
- PBYI $2.64
- RMNI $1.98
- Average True Range (ATR)
- PBYI 0.13
- RMNI 0.09
- MACD
- PBYI 0.06
- RMNI 0.03
- Stochastic Oscillator
- PBYI 71.95
- RMNI 46.43
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc is a provider of enterprise software support products and services and a third-party support provider for Oracle and SAP software products based in the United States. The company offers solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. Some of its products include Oracle E-business suite, Oracle Database, Peoplesoft, SAP business suite, and others. The company derives maximum revenue from United states.